Home

Report

Rethinking Clinical Trial Country Prioritization

Rethinking Clinical Trial Country Prioritization

IQVIA
Pages 54 Pages

This report examines declining country and site diversity in clinical trials and its impact on enrollment delays. Despite growing trial complexity, sponsors are using fewer countries, increasing recruitment risk. The analysis evaluates country readiness using patient access, infrastructure, and operational metrics. It identifies underutilized countries with strong potential and calls for global diversification to improve trial agility, resilience, and patient access, particularly in oncology and neurology studies.

Join for free to read

You Might Also Like


Cutting Clinical Trial Costs
Case Study Cutting Clinical Trial Costs
Azenta Life Sciences

Improving the clinical trial process
Case Study Improving the clinical trial process
IBM

Clinical Trial Participant Payments: Navigating Global Complexity and Modern Studies
White Paper Clinical Trial Participant Payments: Navigating Global…
IQVIA

Machine Learning to Drive Clinical Trial Efficiency via Adverse Event Data and Predictions
White Paper Machine Learning to Drive Clinical Trial Efficiency via Adverse…
Revvity Signals

More from IQVIA


Clinical Trial Participant Payments: Navigating Global Complexity and Modern Studies
White Paper Clinical Trial Participant Payments: Navigating Global…
IQVIA

Clinical Trial Disclosure Services
Ebook Clinical Trial Disclosure Services
IQVIA

IQVIA Clinical Trial Financial Suite
Vendor Sheet IQVIA Clinical Trial Financial Suite
IQVIA

Innovative Approaches to Clinical Trial Financial Management
Ebook Innovative Approaches to Clinical Trial Financial Management
IQVIA
© 2026 Contentree.  All Rights Reserved   |   Privacy and Cookies   |   Legal   |   Do not sell my info